Geneva, Oct. 15 -- International Clinical Trials Registry received information related to the study (ChiCTR2600134024) titled 'Correlation of Metabolic Reprogramming with Malignant Progression and Clinical Prognosis in Glioma' on Oct. 10.
Study Type: Observational study
Study Design:
Cohort study
Primary Sponsor: Henan Provincial People's Hospital
Condition:
Glioma
Intervention:
Prospective Recurrent Group:None
Progression Group:None
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-10-20
Target Sample Size: Prospective Recurrent Group:10;Progression Group:100;Non-progression Group:200;
Countries of Recruitment:
China
To know more, visit https://www.chictr.org.cn/showproj.html?proj=343937
Disc...